Skip to content

PIMA - Individualized Adherence Improvement Plan

Study on an Individualized Plan to Improve Patient Compliance to Therapy, Based on Stratification and Use of Telemonitoring for Sleep Apnea With CPAP

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04650061
Acronym
PIMAGASOXMED
Enrollment
200
Registered
2020-12-02
Start date
2020-10-01
Completion date
2021-06-30
Last updated
2020-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea, Obstructive

Brief summary

Continuous positive airway pressure (CPAP) is the first-line treatment for sleep apnoea/hypopnoea syndrome (OSA). The aim of this study is to know the results in adherence to CPAP and health related outcomes in patients with OSA through a comprehensive and multidisciplinary program based on stratification and individualized care plans, including the motivational interview. Methods: A multicenter randomized controlled trial (RCT) is designed. The control group will follow the usual treatment, while the intervention group (PIMA) will follow the treatment according to the stratification label based on a comprehensive assessment. This label determines a personalized treatment plan for each patient, which includes different channels (home, telephone, care center) and the use of the motivational interview in each of the interventions with the patient. The main outcome was adherence. Secondary outcomes were quality of life, emotional state, activities, social relationships, perceived competence and motivation.

Detailed description

The subjects enrolled in the study are required to have a diagnosis of OSA confirmed by sleep studies with polygraphy (PS) and / or polysomnography(PSG). Prior to enrolment in the study, all patients are informed in detail about the study and signed the consent form to participate. A randomisation process will follow using a random number generator in Statistical Package for the Social Sciences (SPSS) to systematically assign patients to one group or another, with allocation concealment. Responsible for randomization are prescribers. The control group intervention. The patients will follow the standard of care, which consists of starting therapy in the home, where the nurse perform training in the use of CPAP equipment, mask adjustment, and safety and maintenance instructions. For follow-up, the patient is always visited at home or telephone, with a frequency established by the Portuguese Society of Sleep(Day 7, Day 21 and Day 180). The follow-up procedure consists of reviewing the CPAP hour meter and resolving any incidents that may have arisen, with the necessary corrective actions (change of mask, positive reinforcement, explanation of specific aspects). The intervention group 'PIMA' (Personalized Adherence Improvement Plan, based on the Spanish acronym), starts the treatment with the educational and training program called MEntA (Motivational Interview for Adherence). MEntA intervention consists of one session lasting approximately 60 minutes, which is divided into two blocks: educational activity and training activity. In the first block, nurse explains the concepts of sleep apnoea and the symptoms, while a patient shows the CPAP treatment and how to optimize this to the fullest. This block is reinforced with documentation in hard copy and digital format. The second block on training activity was based on working with the treatment, equipment, safety, hygiene and advice. MEntA uses the MI to the treatment of OSA with CPAP. In fact, the nurse uses MI not only at the beginning of therapy, but also in every contact that the patient has with the patient throughout the treatment (subsequent follow-up visits, phone calls, etc). For the PIMA group, the nurse was specifically trained to give this intervention to patients, including a training session with a clinical psychologist. After the educational and training program, the nurse performs the stratification process to know a series of patient characteristics that will allow identifying the best care plan to obtain the best results in adherence and quality of life. The stratification labels that determine the personalized intervention plan are obtained from two types of variables: personal and modulation variables.With the psychological and clinical variables, in this first visit, predictive information is obtained on how the patient's adherence will be: high adherence, moderate adherence or low adherence. Taking this information into account, the care plan will start considering how the patient is and their situation with respect to adherence. Low or moderate adherence relative face plans are more intensive than high adherence relative care plans. In follow-up visits (whose frequency depends on the level of adherence), psychological and clinical variables are reviewed and the patient's adherence is added. Depending on their evolution, the care plan is adapted. For patients with low adherence, telemonitoring is used with hours of compliance, the Apnea-hypoanea index(AHI) and air leak.

Interventions

With MI, the key goal is to empower the patient to commit to follow CPAP therapy, while providing empathic support, in a positive atmosphere, and without prejudice. The nurse does not directly advocate for behavior change (i.e. use CPAP as prescribed), but asks key questions to help the patient explore their feelings about the change, weighs the pros and cons of such change, and allows the patient to realize the discrepancy between the current risk (that is, not using CPAP as directed) and the benefits with good adherence.

The nurse takes the compliance of the CPAP device, and ask to the patient if he had some problems.

Sponsors

Hospital Sao Joao
CollaboratorOTHER
Hospital Pedro Hispano
CollaboratorOTHER
Air Liquide Healthcare Spain
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

The patient is informed that he participates in a study to test the efficacy of different care plans, but he is not informed if he belongs to the experimental or to the control group (standard of care)

Intervention model description

A multi-centre randomized, controlled trial (RCT)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Older than 18 years, diagnosis of OSA confirmed by sleep studies with polygraphy (PS) and / or polysomnography (PSG)

Exclusion criteria

* subjects with obesity-related hypoventilation, severe COPD (chronic obstructive pulmonary disease) , cognitive disorders and those unable to understand the consent to participate

Design outcomes

Primary

MeasureTime frameDescription
Change in adherence in the first 6 months of treatmentDay 21, Day 90, Day 120, Day 180Number of hours using CPAP per night
Change in somnolence in the first 6 months of treatmentDay 21, Day 90, Day 120, Day 180Residual sleepiness after use of CPAP. Epworth Test
Change in perceived competence in the first 6 months of treatmentDay 21, Day 90, Day 120, Day 180Self-Efficacy in the CPAP treatment. Perceived Competence Evaluation Questionnaire
Change in Apnea-hypoanea index in the first 6 months of treatmentDay 21, Day 90, Day 120, Day 180Number of apneas-hypoapneas per night
Change in Air Leaks in the first 6 months of treatmentDay 21, Day 90, Day 120, Day 180Fly away through the suitcase adaptation of the mask. Measured in liters / per minute

Secondary

MeasureTime frameDescription
Change in Quality of Life in the first 6 months of treatmentDay 21, Day 90, Day 120, Day 180Well-Being of the patient related to sleep apnea. Analogical Well-Being in Sleep Apnea Scale
Change in Mood in the first 6 months of treatmentDay 21, Day 90, Day 120, Day 180Emotional status related to sleep apnea. Ad hoc question
Change in Activities in the first 6 months of treatmentDay 21, Day 90, Day 120, Day 180Improving general activity after use CPAP. Ad hoc question
Change in Social Relationships in the first 6 months of treatmentDay 21, Day 90, Day 120, Day 180Improving general social relations after use CPAP. Ad hoc question

Countries

Portugal

Contacts

Primary ContactDavid Rudilla, PhD
david.rudilla@airliquide.com+34667126630
Backup ContactAntonio Denis Ferreira
antoniod.ferreira@airliquide.com+(351) 96240 62 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026